ClinConnect ClinConnect Logo
Search / Trial NCT04236037

Ultrasound-guided Biopsy of the Pleura as a Supplement to Extraction of Fluid in Patients With One-sided Fluid in the Pleura

Launched by NAESTVED HOSPITAL · Jan 19, 2020

Trial Information

Current as of May 18, 2025

Terminated

Keywords

ClinConnect Summary

Patients with unilateral pleural effusion with high protein content (exudative pleural effusion) are likely to have malignant pleural effusion. In the Danish guidelines, patient undergo two thoracentesis before more invasive procedures, due to the relatively low incidens of pleural TB and mesothelioma. The aim of the research group is to investigate the effect of early introduction of ultrasound-guided pleural biopsy taken at the optimal sport for thoracentesis. The research group will randomise half of our patients with unilateral pleural exudate to up-front ultrasound-guided biopsy and th...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years.
  • Patients with a previous thoracentesis of a unilateral exudative pleural effusion according to Light's criteria (1) without malignant cells.
  • CT thorax or PET-CT with contrast performed.
  • Clinical suspicion of cancer such as (but not limited to) weight loss or PET-CT results or former cancer diagnosis.
  • Patients must be able to give informed consent.
  • Exclusion Criteria:
  • Bilateral pleural effusions.
  • Known cause of pleural effusions.
  • Life expectancy \<3 months.
  • Inability to understand written or spoken Danish.

About Naestved Hospital

Næstved Hospital is a leading healthcare institution in Denmark dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong commitment to evidence-based practices, the hospital collaborates with multidisciplinary teams of healthcare professionals to design and conduct rigorous studies across various therapeutic areas. Næstved Hospital prioritizes patient safety and ethical standards, ensuring that all clinical trials adhere to regulatory guidelines while fostering an environment of scientific inquiry and collaboration. By participating in clinical research, Næstved Hospital aims to contribute valuable insights to the medical community and enhance the quality of care for patients both locally and globally.

Locations

Næstved, Region Sjælland, Denmark

Roskilde, Zealand, Denmark

Patients applied

0 patients applied

Trial Officials

Uffe Bødtger, MD, PhD,

Principal Investigator

Department of Respiratory Medicine; Naestved Hospital, Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials